NorthCrest Asset Manangement’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$344K Sell
7,100
-11
-0.2% -$565 0.01% 689
2026
Q1
$373K Sell
7,111
-24
-0.3% -$1.56K 0.01% 570
2025
Q4
$446K Sell
7,135
-257
-3% -$15.7K 0.01% 569
2025
Q3
$465K Buy
7,392
+2,175
+42% +$151K 0.01% 519
2025
Q2
$417K Sell
5,217
-2,355
-31% -$197K 0.01% 452
2025
Q1
$651K Buy
+7,572
New +$621K 0.02% 375

Other funds holding PBH

NorthCrest Asset Manangement's PBH Position: Q2 2026 in Review

NorthCrest Asset Manangement reduced its Prestige Consumer Healthcare (PBH) stake by 0.15% in Q2 2026, selling an estimated $565 and leaving 7,100 shares worth $344K. The position accounts for 0.01% of the portfolio, ranked #689.

NorthCrest Asset Manangement first reported a position in PBH in Q1 2025 and has held it in 6 quarters since. The position peaked at $651K in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • NorthCrest Asset Manangement held 7,100 shares of Prestige Consumer Healthcare worth $344K as of Q2 2026.
  • NorthCrest Asset Manangement sold 11 Prestige Consumer Healthcare shares in Q2 2026, an estimated $565.
  • Prestige Consumer Healthcare made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #689 holding.
  • NorthCrest Asset Manangement first reported a position in Prestige Consumer Healthcare in Q1 2025 and has held it in 6 quarters since.
  • NorthCrest Asset Manangement's Prestige Consumer Healthcare position peaked at $651K in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.